Contact
Please use this form to send email to PR contact of this press release:
Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
TO:
Please use this form to send email to PR contact of this press release:
Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
TO: